76 related articles for article (PubMed ID: 27522097)
1. Predictive performance of TPA testing for recurrent disease during follow-up after curative intent surgery for colorectal carcinoma.
van der Sluis FJ; Zhan Z; Verberne CJ; Muller Kobold AC; Wiggers T; de Bock GH
Clin Chem Lab Med; 2017 Feb; 55(2):269-274. PubMed ID: 27522097
[TBL] [Abstract][Full Text] [Related]
2. Value of carcinoembryonic antigen and cytokeratins for the detection of recurrent disease following curative resection of colorectal cancer.
Fernandes LC; Kim SB; Saad SS; Matos D
World J Gastroenterol; 2006 Jun; 12(24):3891-4. PubMed ID: 16804977
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of serum-carcinoembryonic antigen in recurrent colorectal cancer: a receiver operating characteristic curve analysis.
Körner H; Söreide K; Stokkeland PJ; Söreide JA
Ann Surg Oncol; 2007 Feb; 14(2):417-23. PubMed ID: 17103264
[TBL] [Abstract][Full Text] [Related]
4. The Role of TPS and TPA in the Diagnostics of Distant Metastases.
Kucera R; Topolcan O; Fiala O; Kinkorova J; Treska V; Zedníková I; Slouka D; Simanek V; Safanda M; Babuska V
Anticancer Res; 2016 Feb; 36(2):773-7. PubMed ID: 26851038
[TBL] [Abstract][Full Text] [Related]
5. Intensive risk-adjusted follow-up with the CEA, TPA, CA19.9, and CA72.4 tumor marker panel and abdominal ultrasonography to diagnose operable colorectal cancer recurrences: effect on survival.
Nicolini A; Ferrari P; Duffy MJ; Antonelli A; Rossi G; Metelli MR; Fulceri F; Anselmi L; Conte M; Berti P; Miccoli P
Arch Surg; 2010 Dec; 145(12):1177-83. PubMed ID: 21173292
[TBL] [Abstract][Full Text] [Related]
6. Intensified follow-up in colorectal cancer patients using frequent Carcino-Embryonic Antigen (CEA) measurements and CEA-triggered imaging: Results of the randomized "CEAwatch" trial.
Verberne CJ; Zhan Z; van den Heuvel E; Grossmann I; Doornbos PM; Havenga K; Manusama E; Klaase J; van der Mijle HC; Lamme B; Bosscha K; Baas P; van Ooijen B; Nieuwenhuijzen G; Marinelli A; van der Zaag E; Wasowicz D; de Bock GH; Wiggers T
Eur J Surg Oncol; 2015 Sep; 41(9):1188-96. PubMed ID: 26184850
[TBL] [Abstract][Full Text] [Related]
7. The role of carcinoembryonic antigen for the detection of recurrent disease following curative resection of large-bowel cancer.
Wichmann MW; Müller C; Lau-Werner U; Strauss T; Lang RA; Hornung HM; Stieber P; Schildberg FW
Langenbecks Arch Surg; 2000 Jul; 385(4):271-5. PubMed ID: 10958511
[TBL] [Abstract][Full Text] [Related]
8. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
[TBL] [Abstract][Full Text] [Related]
9. Intensive post-operative follow-up of breast cancer patients with tumour markers: CEA, TPA or CA15.3 vs MCA and MCA-CA15.3 vs CEA-TPA-CA15.3 panel in the early detection of distant metastases.
Nicolini A; Tartarelli G; Carpi A; Metelli MR; Ferrari P; Anselmi L; Conte M; Berti P; Miccoli P
BMC Cancer; 2006 Nov; 6():269. PubMed ID: 17116247
[TBL] [Abstract][Full Text] [Related]
10. Serum p53 antibody as tumor marker for follow-up of colorectal cancer after curative resection.
Tang R; Yeh CY; Wang JY; Changchien CR; Chen JS; Hsieh LL
Ann Surg Oncol; 2009 Sep; 16(9):2516-23. PubMed ID: 19565285
[TBL] [Abstract][Full Text] [Related]
11. Postsurgical surveillance for recurrence of UICC stage I colorectal carcinoma: is follow-up by CEA justified?
Yamamoto S; Akasu T; Fujita S; Moriya Y
Hepatogastroenterology; 2005; 52(62):444-9. PubMed ID: 15816454
[TBL] [Abstract][Full Text] [Related]
12. Serum tumor markers in colorectal cancer staging, grading, and follow-up.
Plebani M; De Paoli M; Basso D; Roveroni G; Giacomini A; Galeotti F; Corsini A
J Surg Oncol; 1996 Aug; 62(4):239-44. PubMed ID: 8691835
[TBL] [Abstract][Full Text] [Related]
13. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence.
Lai IR; Lee WJ; Huang MT; Lin HH
Hepatogastroenterology; 2002; 49(46):1157-60. PubMed ID: 12143226
[TBL] [Abstract][Full Text] [Related]
14. Detection of recurrences during follow-up after liver surgery for colorectal metastases: both carcinoembryonic antigen (CEA) and imaging are important.
Verberne CJ; Wiggers T; Vermeulen KM; de Jong KP
Ann Surg Oncol; 2013 Feb; 20(2):457-63. PubMed ID: 22948771
[TBL] [Abstract][Full Text] [Related]
15. Serum carcinoembryonic antigen trends for diagnosing colorectal cancer recurrence in the FACS randomized clinical trial.
Shinkins B; Primrose JN; Pugh SA; Nicholson BD; Perera R; James T; Mant D
Br J Surg; 2018 May; 105(6):658-662. PubMed ID: 29579327
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of CEA, TPA, GICA, CA 72.4, and CA 195 in the Diagnosis of primary colorectal cancer and at its relapse.
Nicolini A; Caciagli M; Zampieri F; Ciampalini G; Carpi A; Spisni R; Colizzi C
Cancer Detect Prev; 1995; 19(2):183-95. PubMed ID: 7750106
[TBL] [Abstract][Full Text] [Related]
17. Comparison of tissue polypeptide antigen (TPA) with cancer antigen 15-3 (CA 15-3) and carcinoembryonic antigen (CEA) in follow-up of breast cancer.
Findeisen R; Albrecht S; Richter B; Deutschmann K; Distler W
Clin Chem Lab Med; 1998 Nov; 36(11):841-6. PubMed ID: 9877089
[TBL] [Abstract][Full Text] [Related]
18. Serum carcinoembryonic antigen monitoring after curative resection for colorectal cancer: clinical significance of the preoperative level.
Park IJ; Choi GS; Lim KH; Kang BM; Jun SH
Ann Surg Oncol; 2009 Nov; 16(11):3087-93. PubMed ID: 19629600
[TBL] [Abstract][Full Text] [Related]
19. Yield of routine imaging after curative colorectal cancer treatment.
Jochmans I; Topal B; D'Hoore A; Aerts R; Vanbeckevoort D; Bielen D; Haustermans K; Van Cutsem E; Penninckx F
Acta Chir Belg; 2008; 108(1):88-92. PubMed ID: 18411580
[TBL] [Abstract][Full Text] [Related]
20. Dynamic assessment of carcinoembryonic antigen in the first month after liver resection for colorectal liver metastases as a rapid-recurrence predictor.
Takamoto T; Sugawara Y; Hashimoto T; Shimada K; Inoue K; Maruyama Y; Makuuchi M
J Surg Oncol; 2016 Mar; 113(4):463-8. PubMed ID: 27100029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
